Multi-omics characterisation of improved cognitive functions in Parkinsonâ€™s Disease patients after the Combined Metabolic Activators treatment: A randomised, double-blinded, placebo-controlled phase-II trial![image](https://github.com/hoaltay/CMA_PD/assets/35534702/97341fab-42be-4772-a04a-53d3a5b665a6)
